Status:
COMPLETED
Knee Osteoarthritis Disabling Pain Program for the Brazilian Unified Health System
Lead Sponsor:
Marta Imamura
Collaborating Sponsors:
Ministry of Health, Brazil
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This is a Randomized Clinical Trial to compare two interventions for reducing knee pain and improving knee function of patients with knee osteoarthritis. Sixty participants will be randomly allocated...
Eligibility Criteria
Inclusion
- Clinical diagnosis of knee osteoarthritis;
- Moderate to severe knee pain (VAS \>= 4);
- Knee pain for at least 3 months prior to inclusion;
- Willing to sign the Informed Consent Form.
Exclusion
- Untreated severe psychological or psychiatric diseases without treatment;
- Presence of fibromyalgia;
- Presence of systemic inflammatory rheumatic diseases;
- Presence of neoplasia;
- Presence of relevant pain in other joints, according to medical evaluation;
- Presence of intolerance or allergy to Lidocaine or local anaesthetics;
- Concomitant use of anticoagulant drug.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2025
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT05286775
Start Date
March 15 2022
End Date
May 30 2025
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Medicina Física e Reabilitação (IMREA-FMUSP)
São Paulo, São Paulo, Brazil, 04101-300